How Bariatric Surgery Affects Cancer Risk — Mechanistic R21 (no clinical trials)
The NCI invites R21 applications to study biological mechanisms by which bariatric surgery (especially RYGB and sleeve gastrectomy) changes cancer risk using animal models and/or human biospecimens; clinical trials are not allowed. Projects must link molecular, microbial, or metabolic mechanisms to actual cancer endpoints rather than epidemiology or biomarker-only outcomes, and multidisciplina…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers